Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design

被引：129

作者：

Zolla-Pazner, Susan ^{[1
,2
]}

Cardozo, Timothy ^{[3
]}

机构：

[1] Harbor Healthcare Syst, Vet Affairs New York, New York, NY 10010 USA

[2] New York Univ, Dept Pathol, Sch Med, New York, NY 10016 USA

[3] New York Univ, Dept Pharmacol, Sch Med, New York, NY 10016 USA

来源：

NATURE REVIEWS IMMUNOLOGY | 2010年 / 10卷 / 07期

基金：

美国国家卫生研究院;

关键词：

IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; EPITOPE FINE SPECIFICITY; N-LINKED GLYCOSYLATION; AMINO-ACID CHANGES; MEMORY B-CELL; NEUTRALIZING ANTIBODIES; BINDING-SITE; V3; LOOP; HIV-1-INFECTED INDIVIDUALS;

D O I：

10.1038/nri2801

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

One of the main challenges of developing an HIV-1 vaccine lies in eliciting immune responses that can overcome the antigenic variability exhibited by HIV. Most HIV-1 vaccine development has focused on inducing immunity to conserved regions of the HIV-1 envelope. However, new studies of the sequence-variable regions of the HIV-1 gp120 envelope glycoprotein have shown that there are conserved immunological and structural features in these regions. Recombinant immunogens that include these features may provide the means to address the antigenic diversity of HIV-1 and induce protective antibodies that can prevent infection with HIV-1.

引用

页码：527 / 535

页数：9

共 104 条

[1]

ALMOND D, AIDS RES HU IN PRESS

[2] Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope [J].

Arnold, Gail Ferstandig ;

Velasco, Paola K. ;

Holmes, Andrew K. ;

Wrin, Terri ;

Geisler, Sheila C. ;

Phung, Pham ;

Tian, Yu ;

Resnick, Dawn A. ;

Ma, Xuejun ;

Mariano, Thomas M. ;

Petropoulos, Christos J. ;

Taylor, John W. ;

Katinger, Hermann ;

Arnold, Eddy .

JOURNAL OF VIROLOGY, 2009, 83 (10) :5087-5100

[3] HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells [J].

Arthos, James ;

Cicala, Claudia ;

Martinelli, Elena ;

Macleod, Katilyn ;

Van Ryk, Donald ;

Wei, Danlan ;

Xiao, Zhen ;

Veenstra, Timothy D. ;

Conrad, Thomas P. ;

Lempicki, Richard A. ;

McLaughlin, Sherry ;

Pascuccio, Massimiliano ;

Gopaul, Ravindra ;

McNally, Jonathan ;

Cruz, Catherine C. ;

Censoplano, Nina ;

Chung, Eva ;

Reitano, Kristin N. ;

Kottilil, Shyam ;

Goode, Diana J. ;

Fauci, Anthony S. .

NATURE IMMUNOLOGY, 2008, 9 (03) :301-309

[4] An Atlas of the Thioredoxin Fold Class Reveals the Complexity of Function-Enabling Adaptations [J].

Atkinson, Holly J. ;

Babbitt, Patricia C. .

PLOS COMPUTATIONAL BIOLOGY, 2009, 5 (10)

[5] Structure of antibody f425-b4e8 in complex with a v3 peptide reveals a new binding mode for HIV-1 neutralization [J].

Bell, Christian H. ;

Pantophlet, Ralph ;

Schiefner, Andre ;

Cavacini, Lisa A. ;

Stanfield, Robyn L. ;

Burton, Dennis R. ;

Wilson, Ian A. .

JOURNAL OF MOLECULAR BIOLOGY, 2008, 375 (04) :969-978

[6] Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].

Binley, JA ;

Wrin, T ;

Korber, B ;

Zwick, MB ;

Wang, M ;

Chappey, C ;

Stiegler, G ;

Kunert, R ;

Zolla-Pazner, S ;

Katinger, H ;

Petropoulos, CJ ;

Burton, DR .

JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252

[7] Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C [J].

Binley, James M. ;

Lybarger, Elizabeth A. ;

Crooks, Emma T. ;

Seaman, Michael S. ;

Gray, Elin ;

Davis, Katie L. ;

Decker, Julie M. ;

Wycuff, Diane ;

Harris, Linda ;

Hawkins, Natalie ;

Wood, Blake ;

Nathe, Cory ;

Richman, Douglas ;

Tomaras, Georgia D. ;

Bibollet-Ruche, Frederic ;

Robinson, James E. ;

Morris, Lynn ;

Shaw, George M. ;

Montefiori, David C. ;

Mascola, John R. .

JOURNAL OF VIROLOGY, 2008, 82 (23) :11651-11668

[8] CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].

BOUHABIB, DC ;

RODERIQUEZ, G ;

ORAVECZ, T ;

BERMAN, PW ;

LUSSO, P ;

NORCROSS, MA .

JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013

[9] Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].

Buchbinder, Susan P. ;

Mehrotra, Devon V. ;

Duerr, Ann ;

Fitzgerald, Daniel W. ;

Mogg, Robin ;

Li, David ;

Gilbert, Peter B. ;

Lama, Javier R. ;

Marmor, Michael ;

del Rio, Carlos ;

McElrath, M. Juliana ;

Casimiro, Danilo R. ;

Gottesdiener, Keith M. ;

Chodakewitz, Jeffrey A. ;

Corey, Lawrence ;

Robertson, Michael N. .

LANCET, 2008, 372 (9653) :1881-1893

[10] Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits [J].

Burke, Brian ;

Gomez-Roman, Victor Raul ;

Lian, Ying ;

Sun, Yide ;

Kan, Elaine ;

Ulmer, Jeffrey ;

Srivastava, Indresh K. ;

Barnett, Susan W. .

VIROLOGY, 2009, 387 (01) :147-156

← 1 2 3 4 5 6 7 8 9 10 →